Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.

Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Published

Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial.

An abstract is available from the original source but is not redistributed by this database. Read the source record.

Open source BibTeX RIS

Read this study in context

This report is included in a selected evidence comparison. Review its population, primary endpoint, findings and limitations alongside the other selected reports.

These original educational annotations are not an exhaustive systematic review or a clinical guideline.

Bibliographic context

Journal
EClinicalMedicine
Date
2023-02-01
Source
PubMed
DOI
10.1016/j.eclinm.2022.101809
PubMed
36636296
Record provenance and attribution

The listed authors receive credit for the original research. This tracker aggregates source metadata and derives discovery labels; inclusion is not scientific validation.

Source identifier
Indexed
2026-07-01 06:48:05 UTC
Metadata last checked
2026-08-09 08:28:17 UTC

Checking metadata does not mean individual manual review. Cite the original work for its findings and the exact dataset snapshot and software version for analyses.

Machine-readable provenance

Authors

Watch author

Derived topics and classifications

These labels are search aids derived from indexed metadata, not an assessment of evidence quality. Verify the study design and findings in the original source.

Citation graph

0 referenced DOIs found in stored source metadata. 20 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Changes in self-related cognitive processes and depressive symptom severity following a single, moderate dose of psilocybin in depressed patients2026-11-10Clinical Evidence on Psilocybin and Its Representation in Media Reporting2026-10-20Beyond Efficacy Signals: Regulatory, Methodological, and Translational Challenges in Clinical Research on Ketamine and Psilocybin in Psychiatry2026-09-01PSYCHEDELICS IN THE TREATMENT OF POST-TRAUMATIC STRESS DISORDER AND DEPRESSION: A REVIEW OF CLINICAL TRIALS2026-08-31Cardiovascular safety of psilocybin in psychiatric practice: a narrative review2026-08-01Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overview2026-07-13Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-Analysis2026-06-15Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations2026-06-01Effect of psilocybin-assisted psychotherapy on anxiety symptoms: A systematic review and meta-analysis2026-05-29Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial2026-05-27Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression2026-05-01The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomes2026-04-21A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depression2026-04-06“You can only take your clients as far as you’ve been yourself”: examining the intersections between psychedelic-assisted therapy, lived-living experience, and clinical practice2026-03-22Synthesis and Characterization of Psilocybin Metabolites and Deuterated Analogs2026-03-18Low-income group psilocybin assisted therapy for depression: An Oregon feasibility study2026-02-12PSILOCYBIN IN PSYCHIATRIC PRACTICE AND PSYCHEDELIC-ASSISTED THERAPY FOR TREATMENT-RESISTANT DEPRESSION2026-01-28Classic psychedelics may treat depressive disorders, but more evidence and legislative changes are required2025-11-04The Legal Perspective on Psilocybin for Medical Use in Czechia: A Key Milestone and the Case for Broader Consideration Beyond the Clinical Setting2025-09-11Five-year outcomes of psilocybin-assisted therapy for Major Depressive Disorder2025-09-04

Related papers